Sildenafil prevents mortality and reduces hippocampal damage after permanent, stepwise, 4-vessel occlusion in rats

Brain Research Bulletin

Volumn 81, Issue 6, 2010, Pages 631-640

  Romanini, Cassia V ^a   Schiavon, Angélica P ^a   Ferreira, Emilene D Fiuza ^a   de Oliveira, Rúbia M Weffort ^a   Milani, Humberto ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

8 Arm aversive radial maze; Chronic 4 vessel occlusion; Hippocampus; Learning and memory; Neuronal damage; Sildenafil

Indexed keywords

SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING; MALE; MAZE TEST; MEMORY; MORPHOMETRICS; MORTALITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANIMALS; CAROTID ARTERY DISEASES; CELL DEATH; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; PIPERAZINES; PURINES; PYRAMIDAL CELLS; RATS; RATS, WISTAR; SULFONES; TIME FACTORS; VASODILATOR AGENTS; VERTEBROBASILAR INSUFFICIENCY;

EID: 76749107948     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.12.012     Document Type: Article

References (49)

1. Arruda-Olson A.M., Mahoney D.W., Nehra A., Leckel M., and Pellikka P.A. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA 287 (2002) 719-725
2. Auer R.N., Jensen M.L., and Whishaw I.Q. Neurobehavioral deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus. J. Neurosci. 9 (1989) 1641-1647
3. Bachevalier J., and Meunier M. Cerebral ischemia: are the memory deficits associated with hippocampal cell loss?. Hippocampus 6 (1996) 553-560
4. Barros C.A., Ekuni R., Mori M.A., Pereira F.M., dos Santos Pereira M.A., and Milani H. The cognitive and histopathological effects of chronic 4-vessel occlusion in rats depend on the set of vessels occluded and the age of the animals. Behav. Brain Res. 197 (2009) 378-387
5. Caretti A., Bianciardi P., Ronchi R., Fantacci M., Guazzi M., and Samaja M. Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1α signaling. Exp. Biol. Med. 233 (2008) 1222-1230
6. Choy M., Ganesan V., Thomas D.L., Thornton J.S., Proctor E., King M.D., van der Weerd L., Gadian D.G., and Lythgoe M.F. The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. J. Cereb. Blood Flow Metab. 26 (2006) 1066-1075
7. Das A., Xi L., and Kukreja R.C. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of nitric oxide signaling. J. Biol. Chem. 280 (2005) 12944-12955
8. Davidson C.M., Pappas B.A., Stevens W.D., Fortin T., and Bennett S.A.L. Chronic cerebral hypoperfusion: loss of papillary reflex, visual impairment and retinal neurodegeneration. Brain Res. 859 (2000) 96-103
9. de la Torre J.C. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol. Res. 26 (2004) 517-524
10. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? data, dogma, and dialectics. Lancet Neurol. 3 (2004) 184-190
11. de la Torre J.C., and Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: role of constitutive nitric oxide. Brain Res. Rev. 34 (2000) 119-136
12. 1-40 accumulation after chronic brain hypoperfusion in rats. Neurol. Res. 25 (2003) 635-641
13. Dirnagl U., Becker K., and Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 8 (2009) 398-412
14. Eklöf B., and Siesjö B.K. The effect of bilateral carotid ligation upon the blood flow and energy state of the rat brain. Acta Physiol. Scand. 86 (1972) 155-165
15. Farkas E., and Luiten P.G.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001) 575-611
16. Farkas E., Luiten P.G.M., and Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 54 (2007) 162-180
17. Fernandes J.S., Mori M.A., Ekuni R., Oliveira R.M.W., and Milani H. Long-term treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia. Nutr. Res. 28 (2008) 798-808
18. Fox G., Gallacher D., Shevde S., Loftus J., and Swayne G. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke 24 (1993) 2087-2092
19. Guazzi M., Samaja M., Arena R., Vicenzi M., and Guazzi M.D. Long-term use of sildenafil in the therapeutic management of heart failure. J. Am. Coll. Cardiol. 50 (2007) 2136-2144
20. He Z., Ibayashi S., Sugimori H., Fujii K., Sadoshima S., and Fujishima M. Age-related ischemia in the brain following bilateral carotid artery occlusion: collateral blood flow and brain metabolism. Neurochem. Res. 22 (1997) 37-42
21. Jaspers R.M.A., Block F., Heim C., and Sontag K.H. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioural and histopathological changes after "2VO" and "four-vessel-occlusion" in rats. Neurosci. Lett. 117 (1990) 149-153
22. Kajta M., Makarewicz D., Ziemińska E., Jantas D., Domin H., Lasoń W., Kutner A., and Łazarewicz J.W. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochem. Int. 55 (2009) 265-274
23. Kukreja R.C., Salloum F., Das A., Ockaili R., Yin C., Bremer Y.A., Fisher P.W., Wittkamp M., Hawkins J., Chou E., Kukreja A.K., Wang X., Marwaha V.R., and Xi L. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vasc. Pharmacol. 42 (2005) 219-232
24. Laidley D.T., Colbourne F., and Corbett D. Increased behavioral and histological variability arising from changes in cerebrovascular anatomy of the Mongolian gerbil. Curr. Neurovasc. Res. 2 (2005) 401-407
25. Li L., Jiang Q., Zhang L., Ding D., Gang Zhang Z., Li Q., Ewing J.R., Lu M., Panda S., Ledbetter K.A., Whitton P.A., and Chopp M. Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res. 1132 (2007) 185-192
26. Miki K., Ishibashi S., Sun L., Xu H., Ohashi W., Kuroiwa T., and Mizusawa H. Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J. Neurosci. Res. 87 (2009) 1270-1281
27. Nagdyman N., Fleck T., Bitterling B., Ewert P., Abdul-Khaliq H., Stiller B., Hübler M., Lange P.E., Berger F., and Schulze-Neick I. Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr. Res. 59 (2006) 462-465
28. Neto C.J.B.F., Paganelli R.A., Benetoli A., Lima K.C.M., and Milani H. Permanent, 3-stage, 4-vessel occlusion as a model of chronic and progressive brain hypoperfusion in rats: a neurohistological and behavioral analysis. Behav. Brain Res. 160 (2005) 312-322
29. Ni J., Ohta H., Matsumoto K., and Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res. 653 (1994) 231-236
30. Nunn J., and Hodges H. Cognitive deficits induced by global cerebral ischaemia: relationship to brain damage and reversal by transplants. Behav. Brain Res. 65 (1994) 1-31
31. Ohta H., Nishikawa H., Kimura H., Anayama H., and Miyamoto M. Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neuroscience 79 (1997) 1039-1050
32. Okada M., Nakanishi H., Tamura A., Urae A., Mine K., Yamamoto K., and Fujiwara M. Long-term spatial cognitive impairment after middle cerebral artery occlusion in rats: no involvement of the hippocampus. J. Cereb. Blood Flow Metab. 15 (1995) 1012-1021
33. Osborne N.N., Casson R.J., Wood J.P.M., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
34. Otori T., Katsumata T., Muramatsu H., Kashiwagi F., Katayama Y., and Terashi A. Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clin. Exp. Pharmacol. Physiol. 30 (2003) 266-272
35. Paganelli R.A., Benetoli A., and Milani H. Sustained neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extrac,t EGb 761, after transient forebrain ischemia in rats. Behav. Brain Res. 174 (2006) 70-77
36. Pappas B.A., de la Torre J.C., Davidson C.M., Keyes M.T., and Fortin T. Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction. Brain Res. 708 (1996) 50-58
37. Paxinos G., and Watson C. The Rat Brain in Sterotaxic Coordinates. 3rd ed. (1997), Academic Press, San Diego, CA
38. Plaschke K. Aspects of ageing in chronic cerebral oligaemia: mechanisms of degeneration and compensation in rat models. J. Neural Transm. 112 (2005) 393-413
39. Plaschke K., Ranneberg T., Bauer J., Weigand M., Hoyer S., and Bardenheuer H.J. The effect of stepwise cerebral hypoperfusion on energy metabolism and amyloid precursor protein (APP) in cerebral cortex and hippocampal in the adult rat. Ann. N. Y. Acad. Sci. 826 (1997) 502-506
40. Plaschke K., Sommer C., Fahrner A., Amann K., Martin E., Bardenheuer H.J., and Knauth M. Pronounced arterial collateralization was induced after permanent rat cerebral four-vessel occlusion: relation to neuropathology and capillary ultrastructure. J. Neural. Transm. 110 (2003) 719-732
41. Roher A.E., Esh C., Kokjohn T.A., Kalback W., Luehrs D.C., Seward J.D., Sue L.I., and Beach T.G. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 2055-2062
42. Rosengarten B., Schermuly R.T., Voswinckel R., Kohstall M.G., Olschewski H., Weissmann N., Seeger W., Kaps M., Grimminger F., and Ghofrani H.A. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension. Cerebrovasc. Dis. 21 (2006) 194-200
43. Royl G., Balkaya M., Lehmann S., Lehnardt S., Stohlmann K., Lindauer U., Endres M., Dirnagl U., and Meisel A. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res. 1265 (2009) 148-157
44. Schwarz E.R., Kapur V., Rodriguez J., Rastogi S., and Rosanio S. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int. J. Impot. Res. 19 (2007) 139-148
45. Sebkhi A., Strange J.W., Phillips S.C., Wharton J., and Wilkins M.R. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 107 (2003) 3230-3235
46. Tárnok K., Kiss E., Luiten P.G.M., Nyakas C., Tihanyi K., Schlett K., and Eisel U.L.M. Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons. Neurochem. Int. 53 (2008) 289-295
47. Thadani U., Smith W., Nash S., Bittar N., Glasser S., Narayan P., Stein R.A., Larkin S., Mazzu A., Tota R., Pomerantz K., and Sundaresan P. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J. Am. Coll. Cardiol. 40 (2002) 2006-2012
48. Zhang L., Zhang Z., Zhang R.L., Cui Y., LaPointe M.C., Silver B., and Chopp M. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res. 1118 (2006) 192-198
49. Zhang R.L., Zhang Z., Zhang L., Wang Y., Zhang C., and Chopp M. Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J. Neurosci. Res. 83 (2006) 1213-1219